TET2 and leukemia: Moreover, administration of Vit-C (1 mM) resembled TET2 recovery, by increasing 5hmC production in Tet2-deficient mice primary murine hematopoietic stem and progenitor cells (HSPCs), as well as suppressing human leukemic colony production and leukemia development in human primary leukemia [185].